Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.
- DOI
- 10.1038/s41417-022-00501-1
- Published
- 2022 Nov
- Container
- Cancer gene therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 4/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41417-022-00501-1,
title = {Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.},
author = {Hu T and Pan C and Zhang T and Ni M and Wang W and Zhang S and Chen Y and Wang J and Fang Q},
year = {2022},
journal = {Cancer gene therapy},
doi = {10.1038/s41417-022-00501-1},
url = {https://doi.org/10.1038/s41417-022-00501-1}
}RIS
TY - JOUR TI - Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4. AU - Hu T AU - Pan C AU - Zhang T AU - Ni M AU - Wang W AU - Zhang S AU - Chen Y AU - Wang J AU - Fang Q PY - 2022 JO - Cancer gene therapy DO - 10.1038/s41417-022-00501-1 UR - https://doi.org/10.1038/s41417-022-00501-1 ER -
APA
T, H., C, P., T, Z., M, N., W, W., S, Z., Y, C., J, W., & Q, F. (2022). Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.. Cancer gene therapy. https://doi.org/10.1038/s41417-022-00501-1
Source records
- pubmed · retrieved 2026-09-26T00:17:34.423Z